Logo image of LVOX

LIVEVOX HOLDINGS INC (LVOX) Stock Fundamental Analysis

NASDAQ:LVOX - Nasdaq - US53838L1008 - Common Stock - Currency: USD

3.73  +0.03 (+0.81%)

After market: 3.73 0 (0%)

Fundamental Rating

3

Taking everything into account, LVOX scores 3 out of 10 in our fundamental rating. LVOX was compared to 283 industry peers in the Software industry. The financial health of LVOX is average, but there are quite some concerns on its profitability. LVOX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LVOX has reported negative net income.
LVOX had a negative operating cash flow in the past year.
In the past 5 years LVOX reported 4 times negative net income.
LVOX had a negative operating cash flow in each of the past 5 years.
LVOX Yearly Net Income VS EBIT VS OCF VS FCFLVOX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -20M -40M -60M -80M -100M

1.2 Ratios

LVOX has a Return On Assets (-14.73%) which is comparable to the rest of the industry.
LVOX's Return On Equity of -27.83% is in line compared to the rest of the industry. LVOX outperforms 45.55% of its industry peers.
Industry RankSector Rank
ROA -14.73%
ROE -27.83%
ROIC N/A
ROA(3y)-25.73%
ROA(5y)-15.15%
ROE(3y)-43.2%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LVOX Yearly ROA, ROE, ROICLVOX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 -20 -40 -60 -80

1.3 Margins

With a Gross Margin value of 66.74%, LVOX perfoms like the industry average, outperforming 53.02% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for LVOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LVOX Yearly Profit, Operating, Gross MarginsLVOX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

LVOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LVOX has more shares outstanding
LVOX has a worse debt/assets ratio than last year.
LVOX Yearly Shares OutstandingLVOX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
LVOX Yearly Total Debt VS Total AssetsLVOX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M

2.2 Solvency

LVOX has an Altman-Z score of 2.16. This is not the best score and indicates that LVOX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of LVOX (2.16) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.59 indicates that LVOX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, LVOX is doing worse than 68.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 2.16
ROIC/WACCN/A
WACC10.29%
LVOX Yearly LT Debt VS Equity VS FCFLVOX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 4.15 indicates that LVOX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.15, LVOX belongs to the best of the industry, outperforming 83.27% of the companies in the same industry.
A Quick Ratio of 4.15 indicates that LVOX has no problem at all paying its short term obligations.
The Quick ratio of LVOX (4.15) is better than 83.27% of its industry peers.
Industry RankSector Rank
Current Ratio 4.15
Quick Ratio 4.15
LVOX Yearly Current Assets VS Current LiabilitesLVOX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

LVOX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.11%, which is quite impressive.
LVOX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.39%.
EPS 1Y (TTM)86.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)8.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.28%

3.2 Future

The Earnings Per Share is expected to grow by 34.87% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.55% on average over the next years. This is quite good.
EPS Next Y92.44%
EPS Next 2Y49.22%
EPS Next 3Y34.87%
EPS Next 5YN/A
Revenue Next Year5.89%
Revenue Next 2Y7.35%
Revenue Next 3Y7.46%
Revenue Next 5Y9.55%

3.3 Evolution

LVOX Yearly Revenue VS EstimatesLVOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
LVOX Yearly EPS VS EstimatesLVOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

LVOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 60.95, LVOX can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as LVOX.
LVOX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE N/A
Fwd PE 60.95
LVOX Price Earnings VS Forward Price EarningsLVOX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LVOX Per share dataLVOX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

LVOX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LVOX's earnings are expected to grow with 34.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.22%
EPS Next 3Y34.87%

More info and screens

0

5. Dividend

5.1 Amount

LVOX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVEVOX HOLDINGS INC

NASDAQ:LVOX (12/22/2023, 8:00:00 PM)

After market: 3.73 0 (0%)

3.73

+0.03 (+0.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-09 2023-11-09/amc
Earnings (Next)02-29 2024-02-29/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.38%
Ins Owner Change0%
Market Cap353.01M
Analysts77.78
Price Target4.07 (9.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)67.86%
Min EPS beat(2)35.71%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)16.54%
Min EPS beat(4)-58.13%
Max EPS beat(4)100%
EPS beat(8)2
Avg EPS beat(8)2.2%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-4.26%
Max Revenue beat(2)0.02%
Revenue beat(4)3
Avg Revenue beat(4)0.8%
Min Revenue beat(4)-4.26%
Max Revenue beat(4)5.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.61%
PT rev (3m)4.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)50%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.63%
Revenue NY rev (1m)-3.09%
Revenue NY rev (3m)-3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 60.95
P/S 2.46
P/FCF N/A
P/OCF N/A
P/B 4
P/tB 13.37
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.06
Fwd EY1.64%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS1.51
BVpS0.93
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.73%
ROE -27.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.74%
FCFM N/A
ROA(3y)-25.73%
ROA(5y)-15.15%
ROE(3y)-43.2%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.8%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.15
Quick Ratio 4.15
Altman-Z 2.16
F-Score4
WACC10.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y92.44%
EPS Next 2Y49.22%
EPS Next 3Y34.87%
EPS Next 5YN/A
Revenue 1Y (TTM)8.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.28%
Revenue Next Year5.89%
Revenue Next 2Y7.35%
Revenue Next 3Y7.46%
Revenue Next 5Y9.55%
EBIT growth 1Y56.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.67%
EBIT Next 3Y50.92%
EBIT Next 5Y34.26%
FCF growth 1Y82.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.6%
OCF growth 3YN/A
OCF growth 5YN/A